Member Info for Saint68

MrsI - that’s the best post on here today.

JHFH- I agree that anyone selling on the back of today’s news needs to give their head a wobble. It wasn’t great but fundamentals haven’t changed.

JHFH - if he knew that these were potentially the same II who previously bought and did the dirty then yes he should have turned them down. Bearing in mind the February raise, he should surely have enough to see us through until the next cohort had been dosed. There will be plenty of catalysts for SP improvement so could possibly have raised more for the same amount of dilution.

JHFH - even you must be surprised by this recent raise - given that we raised £2.5m in February ? Good that it’s at market price with no discount or warrants but 10% of the company given away in 2 months is a sizeable chunk. Vlad and Alexis dropping down the list of major shareholders at a rapid rate of knots.

GHD - thanks for posting that. I have the moron in the bin so hadn’t seen it. What an absolute 🛎️🔚 he is 🤣🤣

A good addition to this site would be a function that when you green binned someone, they then can’t read your posts either.

Totally disagree. If nobody replied, they would leave. Unfortunately there are posters who love the sound of their own voice too much and are incapable of ignoring.

Agreed Haywain. No safety issues is a huge positive.

Would not expect monthly updates but I would have thought that the 12 month survival of patient 1 was a material event.

BBB111 - I agree with most of your post but market sensitive information must be released by RNS and cannot be covered by NDA’s etc. If the 3 patients re still alive, that is definitely market sensitive.

Seawitch - no need to release patient info - just whether all are still alive. This would definitely have a positive effect on the sp.

Not baiting, just answered KP’s question about why I didn’t put everything I have into Hemo and thought he’d reply. As usual you jump in where you weren’t mentioned. It wasn’t that long ago that he was in here bleating that he’d be happy to just get his money back.

You’re just trying to cover the fact that you make ‘factual” statements all the time and most of the time they turn out to just be your opinion.

Out of the 2 of us, you’re the only one who’s actually sold any shares so guess that makes me a firmer believer than you. Just because I vent about the inadequacies doesn’t mean I don’t think the company will be successful. If you didn’t make ridiculous comments, I wouldn’t need to call you out on them. Pretty simple really.

No comment Kingpin ?

Kingping25 “ So if avacta is so great, why would you be on a hemogenyx group chat promoting it and not on the avacta group. I’m a little confused here. Why would you bother investing in hemogenyx and not put all your funds in avacta” - not sure if that was directed at me but if so, have you ever heard the saying “never put all your eggs in one basket “ ? Also I was not promoting, I was answering a question from Jezza - until JHFH stuck his oar in.

I have holdings in both companies (and several others) and expect both to do very well but if someone rubbishes one of my investments I will defend the company - whether that be Avacta here or Hemo on the Avacta board - assuming I can see the offending posts. I have over 1,000 binned posters as I have no time for twats or known imbeciles.

WTF are you you talking about. You seem to be hard of hearing / understanding. I was in both companies way before the twat arrived and I genuinely could not care less what he does as it has no bearing on me at all.

“ you have fallen in love with the years of science at Avacta..” I laughed out loud at that 🤣🤣 Coming from someone who only has eyes for one company and can see no wrong …..

Ps. How do you know what connections I have ? Nearly 40 years in the pharma field has its perks….

I couldn’t give a feck who or what he is. The only person who seems to care is you.

Haywain - “ Removing a fundamental biological impossibility ( a CAR-T for AML that doesn’t induce cytopenia) creates a different class of value than improving how well we exploit a known one (Avactas delivery system). - I would agree that statement when discussing AVA6000 but AVA6103 has shown multiple complete responses across several tumour types. If replicated in humans the market will be massive.

That’s enough from me today - lovely weather here so off for a hike. Enjoy 😊

JHFH - I was happy to call it a day but you can’t help yourself from responding to the twat and mentioning me so..

“ Avacta is the longer, known path that you and saint and others are going to have to keep the punters on and motivated for the next 1-2 years, too many fall off and the CLN becomes a big issue again.” - the longer path has already been done with AVA6000 - 5 years in phase 1 and still no MTD found. The pre|Cision mechanism has now been proven and subsequent candidates will be much quicker through the phases. HEMO have 1 candidate for 1 indication that has dosed 3 patients in 14 months with many hiccups along the way so please don’t pretend it’s all sweetness and light. I would comment on CDX and CBR but due to the comms from Vlad, we have no idea what’s happening with them…

Haywain - I can also keep it simple. Both have the “potential” to be curative imo - especially with the 2nd (and maybe 3rd) candidate at Avacta. The market for solid tumours is far bigger than the blood cancers that we are targeting here. I believe both companies will do very very well over the next year or so.

JHFH - “ Avacta are not much ahead of Hemo and they keep wasting money on new prospects..” - sorry but that’s rubbish.

“ You and alde were saying the same thing when hemo was under 10m mcap and now? 500% higher, not on licence or takeover but simple maths and removal of brokers” - please don’t lump me in with that twat and you’ve been saying for the last 4 or 5 years that the SP was not sustainable yet here we sat at 2 pence old money. We’ve been diluted around 100% since consolidation so saying 500% higher is meaningless. You’re just picking points in time that suit your narrative but that works both ways.

As I’ve said previously, I don’t want to fall out about it so I’ll leave it there. Don’t want to clog the board with other shares and my original post was only due to a request from Jezza.

No idea what that twat posts so I can only see your replies rubbishing Avacta. I’ve done plenty of due diligence on them and am very comfortable with my investment. Currently up over 60% due to a good average but plenty more to come imo. The only way Hemo becomes a better investment is if CBR proves to be as advertised but, for me, that’s way down the line as it’s in a very early stage of development. Hopefully Vlad deems us worthy of an update soon but won’t hold my breath. I think you’re a bit mad too but keep wearing the rose tinted specs and maybe our time will come here.

JHFH - not getting into a debate but you’re absolutely blineded by Hemo and don’t seem open to any other company being able to do any better. Some of your comments below are ridiculous. Take a look at addressable market regarding blood cancers and solid tumours and the amount of warheads that could be added to pre|Cision. Enjoy the rest of your weekend.